Cardiovascular System 1 Flashcards
Inhibitors of RAAS
- Sympathetic blockers (B blockers)
- Direct renin inhibitor (aliskiren)
- ACE
- ARB
- Aldosterone antagonist (spironolactone)
Examples of ACE
Captopril
Enalapril
Ramipril
MOA of ACE
Inhibit angiotensin converting enzyme and hence bp falls due to vasodilation due to decrease in PVR and increase in compliance of large vessels.
Fall in BP dependent on Na+ levels
Angiotensin 1 converted to 1-7 which are vasodilators
Also inhibit substance P/bradykinin which is also converted by ACE
Pharmacokinetics of ACE
Food in stomach decreases bioavailability
70% absorbed
ADR of ACE inhibitors
Hypotension
Hyperkalemia
Cough
Dysgeusia
Angioedema
Rashes, urticaria
Foetopathic
Headache dizziness vomiting
Acute renal failure
Interactions of ACE inhibitors
Diuretics
NSAID like indomethacin
K+ sparing diuretics
Antacids
Uses of ACE inhibitors
Hypertension
CHF
MI
Prophylaxis is high risk CAD
Diabetic nephropathy
Non diabetic nephropathy
Scleroderma crisis
Advantages of using ACE inhibitors in hypertension
Free of postural hypotension
No CNS effects
Can be used in asthmatics, PVD, diabetics
Long term reduce incidence of Diabetes Type 2
No K+ loss
Renal blood flow maintained
LVH reversed
ACE inhibitors first choice in
Diabetics with hypertension
Renovascular and resistant hypertension
ARB examples
Losartan
Telmisartan
Valsartan
MOA of ARB
Competitive antagonist and inverse agonist of AT receptors
All actions of angiotensin: vasoconstriction, sympathetic stimulation, release of aldosterone and adr, renal actions promotinh salt and water Reabsorbtion, vasopressin release all inhibited
Advantages of ARB over ACE inhibitors
Do not interfere with degradation of bradykinin or substance P hence no cough
No angioedema commonly
No dysgeusia
Complete blockade of AT1 receptor
Oral absorption not affected by food
ADR of ARB
Hypotension
Hyperkalemia
Fetopathic
Headache dizziness weakness GI side effects
Uses of ARB
Hypertension
CHF
Diabetic nephropathy
MI
Example of direct renin inhibitor and MOA
Aliskiren
Acts by blocking attachment of angiotensinogen by binding to renin